je.st
news
Home
› Keryx pill for kidney disease patients cleared, but with safety warnings attached, shares fall
Keryx pill for kidney disease patients cleared, but with safety warnings attached, shares fall
2014-09-05 22:05:57| Biotech - Topix.net
Keryx Biopharmaceuticals shares fell Friday as the company received U.S. approval for its pill to treat kidney disease complications but the clearance required unexpected safety warnings. The Food and Drug Administration approved the company's ferric citrate drug to treat patients on dialysis with hyperphosphatemia, or elevated levels of phosphates, which can increase the risk of heart disease, bone density problems and death.
Tags: fall
safety
attached
disease
Category:Biotechnology and Pharmaceuticals